Sanofi’s experimental drug for a form of multiple sclerosis delayed the progression of disability by nearly a third, ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...

Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...

Novartis AG (NYSE:NVS) released new data Wednesday from the ALITHIOS open-label extension study. Data show first-line ...

Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an ...

Key biomarkers identified can now predict disability progression in multiple sclerosis, offering potential for more ...

A new study reveals how gender disparities cause therapeutic inertia in MS treatment for women, highlighting delays and ...

"Those with the highest burden of comorbidity had over a 30% increased risk of having disability worsening," Salter said. "In ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...